RhumbLine Advisers’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
75,070
+11,881
| +19% | +$280K | ﹤0.01% | 1952 |
|
|
2025
Q1 | $1.52M | Buy |
63,189
+4,600
| +8% | +$110K | ﹤0.01% | 1956 |
|
|
2024
Q4 | $2.48M | Buy |
58,589
+6,515
| +13% | +$276K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $2.3M | Sell |
52,074
-2,785
| -5% | -$123K | ﹤0.01% | 1828 |
|
|
2024
Q2 | $1.98M | Sell |
54,859
-2,888
| -5% | -$104K | ﹤0.01% | 1890 |
|
|
2024
Q1 | $2.49M | Buy |
57,747
+9,748
| +20% | +$420K | ﹤0.01% | 1791 |
|
|
2023
Q4 | $738K | Sell |
47,999
-412
| -0.9% | -$6.34K | ﹤0.01% | 2436 |
|
|
2023
Q3 | $664K | Buy |
48,411
+5,260
| +12% | +$72.1K | ﹤0.01% | 2432 |
|
|
2023
Q2 | $693K | Buy |
43,151
+15,857
| +58% | +$255K | ﹤0.01% | 2492 |
|
|
2023
Q1 | $212K | Buy |
27,294
+9,241
| +51% | +$71.8K | ﹤0.01% | 2728 |
|
|
2022
Q4 | $349K | Buy |
18,053
+453
| +3% | +$8.76K | ﹤0.01% | 2613 |
|
|
2022
Q3 | $375K | Buy |
17,600
+1,328
| +8% | +$28.3K | ﹤0.01% | 2628 |
|
|
2022
Q2 | $221K | Buy |
16,272
+5,887
| +57% | +$80K | ﹤0.01% | 2894 |
|
|
2022
Q1 | $244K | Buy |
+10,385
| New | +$244K | ﹤0.01% | 2703 |
|